Literature DB >> 27423436

Hepatitis B carrier state among SLE patients: case-control study.

Omer Gendelman1,2, Naim Mahroum1,2, Doron Comaneshter3, Pnina Rotman-Pikielny4, Arnon D Cohen3,5, Howard Amital6,7, Michael Sherf8,9.   

Abstract

The association between hepatitis B and autoimmune disorders has been intriguing for decades. Many reports have speculated on the possible linkage between these two conditions, yet never before data driven from a large national database was utilized in order to investigate this issue. The objective of this study was to investigate the association between SLE and hepatitis B carrier state. Patients with SLE were compared with age- and sex-matched controls regarding the proportion of hepatitis B carrier state in a case-control study. Chi-square and t tests were used for univariate analysis, and a logistic regression model was used for multivariate analysis. The study was performed utilizing the medical database of Clalit Health Services. The study included 5018 lupus patients over the age of 20 years and 25,090 age- and sex-frequency-matched controls without SLE. The proportion of hepatitis B carriers was higher in SLE patients as compared to controls (0.9 and 0.56 %, respectively; p < 0.001). A significant association was also observed among patients in lower socioeconomic status. In a multivariate logistic regression analysis, SLE was significantly associated with hepatitis B (OR = 1.828, 95 % CI = 1.291-2.590). Patients with SLE have a greater proportion of hepatitis B carrier state than matched controls.

Entities:  

Keywords:  Autoimmune disease; Carrier; Hepatitis B; Infections; SLE

Mesh:

Year:  2017        PMID: 27423436     DOI: 10.1007/s12026-016-8834-6

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  49 in total

1.  Ethnic differences in the prevalence of hepatitis B surface antigen among Israeli blood donors: changes between 1972 and 1988.

Authors:  S Bar-Shany; M S Green; R Slepon; E Gilon
Journal:  Int J Epidemiol       Date:  1991-03       Impact factor: 7.196

2.  Hepatitis B and C viruses serology in patients with SLE.

Authors:  M Abu-Shakra; S El-Sana; M Margalith; E Sikuler; L Neumann; D Buskila
Journal:  Lupus       Date:  1997       Impact factor: 2.911

3.  A potential explanation of the reported low prevalence of hepatitis B virus infection in patients with systemic lupus erythematosus.

Authors:  William H James
Journal:  Rheumatol Int       Date:  2011-03-10       Impact factor: 2.631

Review 4.  Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden.

Authors:  N Danchenko; J A Satia; M S Anthony
Journal:  Lupus       Date:  2006       Impact factor: 2.911

5.  Hepatitis B virus infection in patients with rheumatic diseases.

Authors:  H Permin; J Aldershvile; J O Nielsen
Journal:  Ann Rheum Dis       Date:  1982-10       Impact factor: 19.103

6.  Hepatitis B virus infection and liver function in patients with systemic lupus erythematosus.

Authors:  R P Bonafede; M van Staden; P Klemp
Journal:  J Rheumatol       Date:  1986-12       Impact factor: 4.666

Review 7.  Understanding the epidemiology and progression of systemic lupus erythematosus.

Authors:  Guillermo J Pons-Estel; Graciela S Alarcón; Lacie Scofield; Leslie Reinlib; Glinda S Cooper
Journal:  Semin Arthritis Rheum       Date:  2009-01-10       Impact factor: 5.532

8.  Low prevalence of hepatitis B virus infection in patients with systemic lupus erythematosus in southern China.

Authors:  Jijun Zhao; Minli Qiu; Meirong Li; Caisheng Lu; Jieruo Gu
Journal:  Rheumatol Int       Date:  2009-10-14       Impact factor: 2.631

Review 9.  The geoepidemiology of systemic lupus erythematosus.

Authors:  Andrea T Borchers; Stanley M Naguwa; Yehuda Shoenfeld; M Eric Gershwin
Journal:  Autoimmun Rev       Date:  2009-12-24       Impact factor: 9.754

10.  Hepatitis B Virus Infection Rate and Distribution in Chinese Systemic Lupus Erythematosus Patients.

Authors:  Xumin Chen; Lingyao Hong; Wang Zhang; Meng Yuan; Qiongqiong Yang; Haiping Mao; Wei Chen; Xueqing Yu
Journal:  Med Sci Monit       Date:  2015-07-06
View more
  6 in total

1.  Characterization of adherence and persistence profile in a real-life population of patients treated with adalimumab.

Authors:  Omer Gendelman; Dahlia Weitzman; Vered Rosenberg; Varda Shalev; Gabriel Chodick; Howard Amital
Journal:  Br J Clin Pharmacol       Date:  2018-01-25       Impact factor: 4.335

2.  Chronic hepatitis B viral infection among RA patients-a cross-sectional control study.

Authors:  Naim Mahroum; Abdulla Watad; Shmuel Tiosano; Ashraf Hejly; Hussein Mahagna; Roy Waknin; Doron Comaneshter; Arnon D Cohen; Howard Amital
Journal:  Clin Rheumatol       Date:  2019-02-08       Impact factor: 2.980

3.  Novel clinical and therapeutic aspects in autoimmunity.

Authors:  Howard Amital; Abdulla Watad; Zoltán Szekanecz
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

4.  Chronic hepatitis C viral infection among SLE patients: the significance of coexistence.

Authors:  Naim Mahroum; Ashraf Hejly; Shmuel Tiosano; Omer Gendelman; Doron Comaneshter; Arnon D Cohen; Howard Amital
Journal:  Immunol Res       Date:  2017-04       Impact factor: 2.829

5.  Unilateral Vocal Cord Paralysis of a Great Jewish Opera Singer.

Authors:  Irit Duek; Jacob T Cohen; Ziv Gil
Journal:  Rambam Maimonides Med J       Date:  2018-01-29

6.  Prevalence of hepatitis B virus and hepatitis C virus infection in patients with systemic lupus erythematosus: a systematic review and meta-analysis.

Authors:  Sen Wang; Yuxin Chen; Xuejing Xu; Wei Hu; Han Shen; Junhao Chen
Journal:  Oncotarget       Date:  2017-11-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.